Biotech

All Articles

Arch closes $3B-plus fund to nurture biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Capital Life Sciences, Arc Endeavor Allies is pr...

Orion to utilize Aitia's 'digital identical twins' to discover new cancer cells medicines

.Finnish biotech Orion has actually spied prospective in Aitia's "digital double" specialist to cult...

Windtree's surprise med brings up high blood pressure in newest phase 2 win

.While Windtree Therapeutics has battled to expand the financial roots required to make it through, ...

2 cancer biotechs merge, making worldwide impact

.OncoC4 is taking AcroImmune-- and also its own in-house medical manufacturing abilities-- under its...

Amgen documents very first period 3 gain for $400M eczema medicine

.Amgen has actually shared (PDF) the very first stage 3 information on its $400 million chronic ecze...

Biogen, UCB report phase 3 lupus gain after neglecting earlier trial

.Biogen and also UCB's depend developing right into phase 3 astride a failed study aims to have repa...

Aptadir hopes brand-new RNA preventions can easily reverse difficult cancers

.Italian biotech Aptadir Therapies has actually introduced along with the commitment that its own pi...

Wave surfs DMD success to regulators' doors, sending stock up

.Wave Lifestyle Sciences has met its own goal in a Duchenne muscle dystrophy (DMD) study, positionin...

Sanofi picks brand-new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, taking up th...

Achilles trickles cell treatment course, supports for layoffs after skipping 'office viability' objectives

.Achilles Therapies has shreded its own strategy. The British biotech is actually quiting working on...